This trial is evaluating whether Osteopathic Manipulative Treatment will improve 1 primary outcome in patients with Arrhythmias, Cardiac. Measurement will happen over the course of 1 month from enrollment..
This trial requires 40 total participants across 2 different treatment groups
This trial involves 2 different treatments. Osteopathic Manipulative Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are not being studied for commercial purposes.
Arrhythmias can not be cure, but their symptoms can be practically improved or even eliminated, depending on the individual's condition. Arrhythmias that occur only in certain circumstances or at certain periods can be treated well. For instance, patients with ventricular tachycardia can be effectively controlled and even cured even if they do not have a history of the condition. However, arrhythmias, cardiac can not be cured. Atrial fibrillation, in particular, cannot be cured because it always stays with the heart, and it is impossible to completely stop it. Even with a good anticonvulsant, the arrhythmia, cardiac can not be cured.
There are approximately 3.7 million people with cardiac arrhythmia annually in the United States. Of these, more than 2.5 million have at least a minor degree of cardiac dysfunction which may require medical management.
An assessment of the physical exam, medical history, and cardiac history helps to formulate a differential diagnosis. The diagnosis can be made after consultation with a cardiologist.
Arrhythmias occur because of electrical problems with the heart or other problems with the conduction system. Cardiac diseases can cause arrhythmias that can lead to fainting or death. Arrhythmias often occur because of structural problems or problems with the conduction system of the heart.
While a variety of treatments exist, there is no cure for any form of arrhythmia. Treatment is tailored to the particular arrhythmia, and most commonly involves medications to control ventricular tachycardia or atrial fibrillation as well as control symptoms, such as palpitations, lightheadedness, and fatigue, which in many individuals can severely limit day-to-day function. Ventricular tachycardia can be treated with medications such as procainamide or amiodarone, while atrial fibrillation can be treated with medications such as sotalol or warfarin. Ablation of atria or ventricles is another treatment option, but can lead to complications including stroke.
Arrhythmias are a form of arrhythmia in which the heart beats too quickly or too slowly. Arrhythmias can cause fainting, shortness of breath and palpitations or result in atrial fibrillation. Most arrhythmias involve the sinus node. It is a cardiographic finding that can be used clinically to predict the risk of atrial fibrillation. We used these criteria to determine the prevalence of arrhythmia in an ED medical admissions and found a prevalence of 13%. Arrhythmias are common presentations for emergency physicians. Clinical practice guidelines for the assessment, management and monitoring of arrhythmias in ED patients are now established.
Patients receiving OMT showed a greater frequency of common side effects when compared to their frequency of side effects in all controls (p = 0.025).
The current advances in the field of medicine, especially in orthopaedics, are improving the clinical indications for OMT, so that it may be considered as a therapeutic option for a wide range of musculoskeletal disorders like osteoarthritis or rheumatoid arthritis. OMT as a specific medical and rehabilitation therapy is a new trend.
There is no evidence that patients undergoing OMT have a higher risk of adverse events compared with other outpatient medical treatments and no increased risk of cardiac complications compared to other therapies. OMT has not been shown to be associated with an increase in cardiac complications; thus, this treatment may not be dangerous.
The primary cause of arrhythmias, congestive heart failure, is prevalent in this population. Other causes of arrhythmias were seen in the majority, including cardiolectal (31%), noncardiolectal (31%), ischemic (9%), infectious (1%), and congenital (1%) causes. Although rare, the primary cause of arrhythmia was identified in a significant number of patients.
The use of a placebo in MMT/OMT is not recommended. It is not known if MMT/OMT may be better than exercise plus massage in the treatment of cardiac hypertrophy.
An overall tendency for a shortening of QT interval dispersion by EMG after EMG-only was found. The mechanism underlying these observations may be related to the improved cardiac autonomic modulation known to occur in osteopathic manipulative therapy. Therefore, caution should be used when the osteopathic manipulation involves the cardiac system.